| Literature DB >> 32574242 |
Jia Liu1,2, Qing Zhu3, Wenliang Fan1,2, Joyman Makamure1,2, Chuansheng Zheng1,2, Jing Wang1,2.
Abstract
Background: The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, Hubei province, has led to the quarantine of many residents in their homes, in order to mitigate its spread. Some of these people developed mental health problems, and many solutions have been put in place to address the mental health issues of patients and health professionals affected by the disease. However, not much attention has been given to students, particularly those from medical school. The present study aims to conduct an online survey to investigate the mental health status of students from a medical college in Hubei province. Materials andEntities:
Keywords: COVID-19; GAD-7; PHQ-9; anxiety; depression
Year: 2020 PMID: 32574242 PMCID: PMC7237734 DOI: 10.3389/fpsyt.2020.00459
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Demographic characteristics of the participants in the survey.
| Participants (n=217) | |
|---|---|
| Age(y) | 21.7 ± 1.7 (18-27) |
| Grade | |
| 1 | 9 (4.1%) |
| 2 | 9 (4.1%) |
| 3 | 85 (39.2%) |
| 4 | 52 (24.0%) |
| 5 | 35 (16.1%) |
| 7 | 27 (12.5%) |
|
| |
| Male | 90 (41.5%) |
| Female | 127 (58.5%) |
|
| |
| Inside Hubei province | 50 (23.0%) |
| Outside Hubei province | 167 (77.0%) |
|
| |
| 0-4 (asymptomatic) | 140 (64.5%) |
| 5-9 (mild) | 53 (24.4%) |
| 10-14 (moderate) | 22 (10.1%) |
| 15-19 (moderate to severe) | 1 (0.5%) |
| 20-27 (severe) | 1 (0.5%) |
|
| |
| 0-4 (asymptomatic) | 169 (77.9%) |
| 5-9 (mild) | 32 (14.7%) |
| 10-14 (moderate) | 14 (6.4%) |
| 15-21 (severe) | 2 (1.0%) |
GAD-7, Generalized Anxiety Disorder-7; PHQ-9, Patient Health Questionnaire-9; y, year.
The Questionnaire results of PHQ-9 and GAD-7.
| Gender | Geographical position | Grade | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male (n=90) | Female (n=127) | P value | Inside Hubei province (n=50) | Outside Hubei province (n=167) | P vlaue | 1 (n=9) | 2 (n=9) | 3 (n=85) | 4 (n=52) | 5 (n=35) | 7 (n=27) | P vlaue | |
|
| P=0.155 | P=0.356 | P=0.097 | ||||||||||
| 0-4 (asymptomatic) | 63(70.0%) | 77(60.6%) | 35(70.0%) | 105(62.9%) | 7(77.8%) | 5(55.6%) | 50(58.8%) | 39(75.0%) | 26(74.3%) | 13(48.1%) | |||
| ≥5(symptomatic) | 27(30.0%) | 50(39.4%) | 15(30.0%) | 62(37.1%) | 2(22.2%) | 4(44.4%) | 35(41.2%) | 13(25.0%) | 9(25.7%) | 14(51.9%) | |||
| Stage | P=0.521 | P=0.911 | P=0.089 | ||||||||||
| 5-9 (mild) | 20(22.2%) | 33(26.0%) | 10(20.0%) | 43(25.7%) | 0(0.0%) | 4(44.4%) | 24(28.2%) | 11(21.2%) | 4(11.4%) | 10(37.0%) | |||
| 10-14 (moderate) | 6(6.7%) | 16(12.6%) | 5(10.0%) | 17(10.2%) | 2(22.2%) | 0(0.0%) | 9(10.6%) | 2(3.8%) | 5(14.3%) | 4(14.9%) | |||
| 15-19 (moderate to severe) | 0(0.0%) | 1(0.8%) | 0(0.0%) | 1(0.6%) | 0(0.0%) | 0(0.0%) | 1(1.2%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | |||
| 20-27 (severe) | 1(1.1%) | 0(0.0%) | 0(0.0%) | 1(0.6%) | 0(0.0%) | 0(0.0%) | 1(1.2%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | |||
|
| P=0.526 | P=0.981 | P=0.220 | ||||||||||
| 0-4 (asymptomatic) | 72(80.0%) | 97(76.4%) | 39(78.0%) | 130(77.8%) | 6(66.7%) | 7(77.8%) | 65(76.5%) | 45(86.5%) | 29(82.9%) | 17(63.0%) | |||
| ≥5(symptomatic) | 18(20.0%) | 30(23.6%) | 11(22.0%) | 37(22.2%) | 3(33.3%) | 2(22.2% | 20(23.5%) | 7(13.5%) | 6(17.1%) | 10(37%) | |||
| Stage | P=0.747 | P=0.582 | P=0.578 | ||||||||||
| 5-9 (mild) | 13(14.5%) | 19(15.0%) | 8(16.0%) | 24(14.4%) | 1(11.1%) | 1(11.1%) | 15(17.6%) | 6(11.6%) | 4(11.4%) | 5(18.5%) | |||
| 10-14 (moderate) | 3(3.3%) | 11(8.6%) | 3(6.0%) | 11(6.6%) | 2(22.2%) | 1(11.1%) | 3(3.5%) | 1(1.9%) | 2(5.7%) | 5(18.5%) | |||
| 15-21 (severe) | 2(2.2%) | 0(0.0%) | 0(0.0%) | 2(1.2%) | 0(0.0%) | 0(0.0%) | 2(2.4%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | |||
GAD-7, Generalized Anxiety Disorder-7; PHQ-9, Patient Health Questionnaire-9.